You can lead an investor to liquid alternative beta, but will they drink?
| Jul 1st, 2010 | Filed under: Academic Research, Alternative Beta & Hedge Fund Replication, Today's Post | By: AAA Staff |
|
You can lead an investor to liquid alternative beta, but you can’t force him or her to drink it. That’s the tongue-in-cheek sort-of message behind a white paper academic study released by Credit Suisse Asset Management this week on liquid alternative beta (LAB, for short), better known as hedge fund replication.
The report (click here to download in PDF form; click here for Credit Suisse’s LAB Web page) argues that just as index-linked investments in the long-only world have slowly but surely gained traction and acceptance, so too will LAB gain acceptance as an effective diversification and portfolio management tool – eventually.
To continue reading this article please login (at the right) or click here to learn more about accessing our archives.
I’m a firm believer that what you put in can lead to what you get out.